Protalix Bio Therapeutics ( PLX) is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system, ProCellEx. This stock is trading up 3% to $6.43 in recent trading. Today's Range: $6.29-$6.46 52-Week Range: $4.06-$7.16 Volume: 319,000 Three-Month Average Volume: 347,900 From a technical perspective, PLX is gapping up notably higher today on decent volume. This move is quickly pushing the stock within range of triggering a major breakout trade. That trade will hit once PLX takes out some past overheard resistance at $6.70 to $7.28 with high-volume. Traders should now look for long-biased trades in PLX if it can sustain a move or close above those levels with volume that's near or well above 347,900 shares. If we get that action soon, look for PLX to make a run at its next significant overhead resistance level of $10. To see more stocks under-$10 that are making notable moves higher today, check out the Stocks Under-$10 Moving Higher portfolio on Stockpickr. -- Written by Roberto Pedone in Winderemere, Fla.
NewLead Holdings (NEWL) stock is lower in after-hours trading following a judge's decision to deny the company its preliminary injunction attempting to stop Ironridge Global IV from obtaining additional shares of NewLead.
Shares of NewLead (NEWL) are up over 40% after the Greek shipping company announced that the company was granted a Temporary Restraining Order against Ironridge Global IV, Ltd. prohibiting the further issuance of common shares in payment of dividends on Series A Preference Shares of NewLead.